205 related articles for article (PubMed ID: 35755862)
1. CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer.
Wang Z; Zhang S; Zheng C; Xia K; Sun L; Tang X; Zhou F; Ouyang Y; Tang F
Int J Gen Med; 2022; 15():5701-5713. PubMed ID: 35755862
[TBL] [Abstract][Full Text] [Related]
2. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
Front Oncol; 2020; 10():570819. PubMed ID: 33628726
[TBL] [Abstract][Full Text] [Related]
3. CTHRC1 is a prognosis-related biomarker correlated with immune infiltrates in colon adenocarcinoma.
Meng C; Zhang Y; Jiang D; Wang J
World J Surg Oncol; 2022 Mar; 20(1):89. PubMed ID: 35307012
[TBL] [Abstract][Full Text] [Related]
4. CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma.
Zhong R; Yang M; Zhu R; Zhang J; Wang L
Oncol Lett; 2023 Apr; 25(4):133. PubMed ID: 36909370
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers.
Peng D; Wei C; Zhang X; Li S; Liang H; Zheng X; Jiang S; Han L
Cancer Cell Int; 2021 Oct; 21(1):566. PubMed ID: 34702252
[TBL] [Abstract][Full Text] [Related]
6. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
[TBL] [Abstract][Full Text] [Related]
7. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
[TBL] [Abstract][Full Text] [Related]
8. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanisms of CTHRC1 in gastric cancer by integrating TCGA, GEO and GSA datasets.
Zhao L; Wang W; Niu P; Luan X; Zhao D; Chen Y
Front Genet; 2022; 13():900124. PubMed ID: 35928443
[TBL] [Abstract][Full Text] [Related]
10. The expression of
Zhang X; Zheng Y; Liu X; Wang K; Zhao H; Yin Y; Yu Y
Ann Transl Med; 2022 Jan; 10(2):81. PubMed ID: 35282072
[TBL] [Abstract][Full Text] [Related]
11. CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway.
Bai Y; Yin K; Su T; Ji F; Zhang S
Onco Targets Ther; 2020; 13():5743-5753. PubMed ID: 32606786
[TBL] [Abstract][Full Text] [Related]
12. CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.
Li LY; Yin KM; Bai YH; Zhang ZG; Di W; Zhang S
Clin Exp Metastasis; 2019 Aug; 36(4):351-363. PubMed ID: 31119444
[TBL] [Abstract][Full Text] [Related]
13. Identification of
Weng M; Xie H; Zheng M; Hou X; Wang S; Huang Y
Front Genet; 2022; 13():996345. PubMed ID: 36246587
[No Abstract] [Full Text] [Related]
14. Collagen triple helix repeat containing-1 (CTHRC1) expression in invasive ductal carcinoma of the breast: the impact on prognosis and correlation to clinicopathologic features.
Kim JH; Baek TH; Yim HS; Kim KH; Jeong SH; Kang HB; Oh SS; Lee HG; Kim JW; Kim KD
Pathol Oncol Res; 2013 Oct; 19(4):731-7. PubMed ID: 23658133
[TBL] [Abstract][Full Text] [Related]
15. Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis.
Yu Y; Sun X; Chen F; Liu M
Front Genet; 2022; 13():812674. PubMed ID: 35126480
[TBL] [Abstract][Full Text] [Related]
16. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
17. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
[TBL] [Abstract][Full Text] [Related]
18. Joint analysis identified FAP as a prognostic and diagnostic biomarker correlated immune infiltration in gastric cancer.
Zhang K; Yue B; Duan X; Chen W; Dai X; Chen Y; Li X; Lu J
Pathol Res Pract; 2023 May; 245():154462. PubMed ID: 37068372
[TBL] [Abstract][Full Text] [Related]
19. Application Potential of
Pang C; Wang H; Shen C; Liang H
Front Mol Biosci; 2022; 9():849771. PubMed ID: 35300110
[TBL] [Abstract][Full Text] [Related]
20. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
